Where can I take the Metalo-Balance test?

Starting June 24, 2026, at Haruna Co-op Takasaki Central Hospital. Appointment only.

How much blood is needed for the test?

Only 6mL of blood is required to assess both cancer and cognitive risks, minimizing physical burden.

When will I receive my test results?

The invoice arrives about 3 weeks after blood draw, and results about 5 weeks later by mail.

AI News NQ Analysis

【Takasaki City, Gunma Prefecture】Metalo-Balance Test, a 6mL blood draw screening for cancer and cognitive risk, to launch at Takasaki Central Hospital on Wednesday, June 24, 2026

Key facts

【Takasaki City, Gunma Prefecture】Metalo-Balance Test, a 6mL blood draw screening for cancer and cognitive risk, to launch at Takasaki Central Hospital on Wednesday, June 24, 2026
Renatech Inc. has announced the launch of its 'Metalo-Balance Test'—a screening test that assesses cancer and MCI (mild cognitive impairment) risk from just 6mL of blood—at Takasaki Central Hospital starting June 24, 2026. This innovative test, already taken by over 100,000 people nationwide, enables organ-specific cancer risk assessment and comprehensive cognitive risk evaluation.
Source: PR TIMES
Date: Wed Jun 17 2026 20:50:15 GMT+0900 (Japan Standard Time)

Direct answer

Renatech Inc. has announced the launch of its 'Metalo-Balance Test'—a screening test that assesses cancer and MCI (mild cognitive impairment) risk from just 6mL of blood—at Takasaki Central Hospital starting June 24, 2026. This innovative test, already taken by over 100,000 people nationwide, enables organ-specific cancer risk assessment and comprehensive cognitive risk evaluation.

Citation: 【Takasaki City, Gunma Prefecture】Metalo-Balance Test, a 6mL blood draw screening for cancer and cognitive risk, to launch at Takasaki Central Hospital on Wednesday, June 24, 2026 (Wed Jun 17 2026 20:50:15 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Wed Jun 17 2026 20:50:15 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Renatech Inc. has announced the launch of its 'Metalo-Balance Test'—a screening test that assesses cancer and MCI (mild cognitive impairment) risk from just 6mL of blood—at Takasaki Central Hospital starting June 24, 2026. This innovative test, already taken by over 100,000 people nationwide, enables organ-specific cancer risk assessment and comprehensive cognitive risk evaluation.

AI Analysis

Frequently Asked Questions

Q: Where can I take the Metalo-Balance test?: A: Starting June 24, 2026, at Haruna Co-op Takasaki Central Hospital. Appointment only.
Q: How much blood is needed for the test?: A: Only 6mL of blood is required to assess both cancer and cognitive risks, minimizing physical burden.
Q: When will I receive my test results?: A: The invoice arrives about 3 weeks after blood draw, and results about 5 weeks later by mail.